CVE-2026-133693: continuedev continue 2.0.0/2.1.0 · Path Traversal
Source GCVE Database
Not known to be exploited · CVSS 4.8 Medium.
Data as of 20 Nov 2026, 22:43 UTC
Thin evidence
One scorer or none| CNA (VulDB) | CVSS 4.0 | 4.8 |
|---|---|---|
| CNA (VulDB) | CVSS 3.1 | 3.3 |
| CNA (VulDB) | CVSS 3.0 | 3.3 |
| CNA (VulDB) | CVSS 2.0 | 1.7 |
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:XExploitation evidence
Disclosed: evidence found.
CVE published 20 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 20 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| continuedevcontinue | Affected
| Fixed in– |
AI-suggested
Users should restrict local access to trusted personnel and monitor for any updates from the vendor regarding fixes.
Description
A path traversal weakness exists in continuedev continue versions 2.0.0 and 2.1.0 in the validateSearchAndReplaceFilepath function of the Edit Tool component. Exploitation requires local access and can lead to limited integrity impact. The vendor has not responded to disclosure requests, and no patch information is available.